Us – Bioithas

Meet Bioithas

Get to know Bioithas: your trusted research center

An experienced team

Get to know Bioithas: we are a research center made up of a multidisciplinary team of pharmacists, biotechnologists, doctors and engineers, where our day-to-day work consists of developing new probiotic combinations that improve or serve as an adjuvant treatment for different pathologies.

Based on our previous research, we test our products in clinical trials, following the same procedure as a drug, in order to obtain objective and conclusive results for our products. In addition, on many occasions, we publish our articles in the most important indexed journals in the international territory.

What we do at Bioithas

At Bioithas we focus on the study of the composition of the microbiota and its alterations associated with diseases, generating innovative products based on this knowledge: probiotics and biomarkers.

We do all of this by putting great efforts into conducting clinical trials with our products, which guarantee their efficacy and quality.

In addition, we also carry out services for other companies in the sector, helping to promote scientific research.

Discover our products or what services we offer:

Our services Store

Projects

Lines of investigation

Get to know Bioithas: we participate in and lead a multitude of research projects in the field of human microbiota.

Some of our lines of work whose investigations have been carried out or are in progress are:

1 – Study of the efficacy of probiotics and other nutritional supplements for specific pathologies.

Dermatology: Atopic dermatitis Psoriasis, Acne, Rosacea, Alopecia. Neurology: migraine, dementia. Oncology : breast cancer. Digestive: consumption of antibiotics, ulcerative colitis. Others : COVID-19, Fibromyalgia, Overweight

probiotics

2 – Study of the composition of the intestinal microbiota :

Differences associated with body weight

Disease-associated changes: ASD, Diabetes, Psoriasis, Atopic Dermatitis, Multiple Sclerosis, Head and neck cancer.

3 – Validation of biomarkers based on microbiota:

Multiple sclerosis
Head and neck cancer

Discover more information here:

Biomacadores

Our history

Research and clinical studies

Between 2015 and 2016, Dr. Vicente Navarro, CEO and Scientific Director at Bioithas, develops two important investigations with probiotics in skin pathologies , specifically, in psoriasis and atopic dermatitis. These scientific investigations result in two patents, which led to the need to establish Bioithas as a company.

From that moment on, various pharmaceutical laboratories became interested and contacted us to make new developments and, in parallel, we began to promote our own clinical studies in order to generate more knowledge in the field of microbiota and, finally, new probiotic products. and its associated patents.

If you want, you can see the Curriculum Vitae of Dr. Vicente Navarro:

CV of Dr. Vicente Navarro

Our common bond

The human microbiota

In this field there are numerous and recent studies and investigations that relate said microbiota with the health and disease of the individual.

Currently, there is a need to find personalized treatments where a common therapy for all patients does not work correctly, which has determined the importance of seeking specific and individualized solutions.

All this is in the crosshairs of both technology companies and health authorities.

We use this knowledge to develop, within various pathological lines, disease biomarkers on the one hand, and on the other, probiotic products that can act by modulating this microbiota and, consequently, improving the health of the patient."